欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01477 欧康维视生物-B

圣诞节后第一个工作日休市 12-24 12:08:24

7.840

-0.060

-0.76%

最高7.930	最低7.790	成交量37.53万
今开7.920	昨收7.900	日振幅1.77%
总市值63.90亿	流通市值63.90亿	总股本8.15亿
成交额294.22万	换手率0.05%	流通股本8.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"欧康维视生物-B","latestPrice":7.84,"timestamp":1766549304002,"preClose":7.9,"halted":0,"volume":375336,"delay":0,"floatShares":815000000,"shares":815000000,"eps":-0.4356562998725006,"marketStatus":"圣诞节后第一个工作日休市","change":-0.06,"latestTime":"12-24 12:08:24","open":7.92,"high":7.93,"low":7.79,"amount":2942154,"amplitude":0.017722,"askPrice":7.84,"askSize":12000,"bidPrice":7.82,"bidSize":32500,"shortable":3,"etf":0,"ttmEps":-0.3696089374786205,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":7.9,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":1.3969534767345402,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01477","defaultTab":"news","newsList":[{"id":"2594325913","title":"石药创新制药股份有限公司股东会通过多项重要议案，包括变更会计师事务所及补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2594325913","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594325913?lang=zh_cn&edition=full","pubTime":"2025-12-25 18:00","pubTimestamp":1766656800,"startTime":"0","endTime":"0","summary":"中访网数据石药创新制药股份有限公司于2025年12月25日召开了2025年第三次临时股东会。核心决策包括：同意将部分已结项的募集资金投资项目节余资金永久补充流动资金并注销相关专户；批准了公司2026年度与关联方的日常交易预计额度；决议变更公司年度审计会计师事务所；以及授权公司及子公司向银行申请2026年度综合授信额度。其中，关联交易议案因涉及关联方，相关股东已依法回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225180131a6ce2687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225180131a6ce2687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","SG9999004220.SGD","LU0880133367.SGD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE0008368742.USD","LU0140636845.USD","BK1191","01093","LU1226288253.USD","IE00B543WZ88.USD","01477","LU1328277881.USD","LU0314109678.HKD","LU1152091168.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","HK0000165453.HKD","IE0008369823.USD","LU0067412154.USD","LU1226287875.USD","LU0501845795.SGD","LU1226287792.SGD","LU0315179316.USD","IE00B031HY20.USD","LU1951186391.HKD","LU1960683339.HKD","LU0072913022.USD","IE00BZ08YT58.USD","LU2039709279.SGD","LU1807302812.USD","LU1226288170.HKD","LU1226287529.USD","LU1813983027.USD","IE00BZ08YS42.EUR","BK1574","BK1515","LU1152091754.HKD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2593763144","title":"资本涌入、合作爆发，AI制药迈入加速发展期｜记“医”2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2593763144","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593763144?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:04","pubTimestamp":1766570656,"startTime":"0","endTime":"0","summary":"在技术突破的推动下，全球AI制药行业正呈现多点开花的发展态势。摩熵投融资数据显示，今年以来，全球AI制药相关投融资事件近80起。随着技术与资本的双重加持，AI制药有望加速创新药物问世，为全球患者带来新的治疗希望。目前，全球十大制药巨头均已布局AI。另外，据国金证券统计，截至2025年11月21日，今年全球AI制药BD交易已达12项。万联证券指出，企业合作共担风险有利于推动AI制药从“概念”走向“现金流”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224180826a6c9e1e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224180826a6c9e1e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","BK1574","01477","BK1191","03696"],"gpt_icon":1},{"id":"2593403575","title":"每日卖空追踪 | 歌礼制药-B 12月24日卖空量成交16.7万股，卖空比例为16.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593403575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593403575?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565021,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月24日，涨1.69%，卖空量成交16.7万股，较上一交易日减少69.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163320a4727ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163320a4727ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","01477","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2593413090","title":"复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413090","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593413090?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:08","pubTimestamp":1766498900,"startTime":"0","endTime":"0","summary":"证券日报网讯12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599787764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0187","BK1100","BK1222","BK0239","BK0175","BK1583","XBI","159760","BK1574","BK0196","XLV","LABU","BK4581","BK1593","BK4588","01477","BK0188","BK0060","09997","BK4585","BK1191","BK0183","BK1515","BK0096","BK0028","09996","02196","159883","BK0012","600196"],"gpt_icon":0},{"id":"2593432493","title":"石药创新制药股份有限公司控股子公司达雷妥尤单抗注射液获临床试验批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2593432493","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593432493?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:55","pubTimestamp":1766480123,"startTime":"0","endTime":"0","summary":"中访网数据 石药创新制药股份有限公司于近日发布公告，其控股子公司石药集团巨石生物制药有限公司研发的达雷妥尤单抗注射液，已获得国家药品监督管理局核准签发的《药物临床试验批准通知书》，受理号为CXSL2500876。公司表示将于近期启动临床试验。此次获得临床试验批准是该药物研发进程中的关键一步，但后续仍需完成临床试验并经国家药监局批准后方可上市销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251223/31884943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IE0008369823.USD","IE00BZ08YR35.GBP","LU1813983027.USD","IE00BZ08YT58.USD","LU1951186391.HKD","01477","BK1515","IE00B031HY20.USD","LU1226288170.HKD","LU1226287529.USD","LU0326950275.SGD","LU0314109678.HKD","LU1960683339.HKD","BK1191","HK0000165453.HKD","SG9999004220.SGD","LU1226288253.USD","LU2039709279.SGD","LU1993786604.SGD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","01093","LU0140636845.USD","LU0880133367.SGD","LU1226287792.SGD","LU0072913022.USD","IE00B543WZ88.USD","LU1008478684.HKD","LU0315179316.USD","BK1521","LU0501845795.SGD","LU1152091754.HKD","LU1152091168.USD","LU1807302812.USD","LU1226287875.USD","LU1328277881.USD","BK1574","LU0067412154.USD","IE0008368742.USD"],"gpt_icon":0},{"id":"1130488131","title":"港股创新药概念股盘中拉升！石药集团涨超5%，荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130488131","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130488131?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:04","pubTimestamp":1766455472,"startTime":"0","endTime":"0","summary":"12月23日，港股创新药概念股盘中拉升，$石药集团(01093)$涨超5%，$恒瑞医药(01276)$、$三生制药(01530)$涨近3%，$先声药业(02096)$、$歌礼制药-B(01672)$、$康诺亚-B(02162)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"26e483f2c2080ad5ab71efdf30a08f1a","theme_name":"🔥热榜No.45 · 石药集团获主席蔡东晨增持引发股价大幅上涨","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","02162","01093","06978","01477","01276","02096","01530"],"gpt_icon":0},{"id":"2593414568","title":"齐鲁制药旗下申可安在阿里健康首发为“剂末现象”帕金森病患者提供新选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2593414568","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593414568?lang=zh_cn&edition=full","pubTime":"2025-12-23 09:52","pubTimestamp":1766454720,"startTime":"0","endTime":"0","summary":"12月22日，齐鲁制药旗下恩他卡朋双多巴片(Ⅱ)（申可安）在阿里健康首发。该药适用于治疗经左旋多巴/多巴脱羧酶抑制剂疗法未能控制的“剂末”运动功能波动的成人帕金森病患者。申可安整合三种成分制成单一复方片剂，可提高左旋多巴入脑水平，延长其半衰期，减轻外周不良反应，简化用药方案，提升患者依从性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223100739a6c3bc63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223100739a6c3bc63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1142","BK1247","BK1571","01477","BK1191","00241","BK1502","BK1501","BK1515","BK1574","BK1615","BK1189","BK1610","BK1617","BK1591","BK1589","BK1584"],"gpt_icon":0},{"id":"2593485449","title":"歌礼制药-B(01672)12月22日斥资249.37万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485449?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:54","pubTimestamp":1766397251,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月22日，该公司斥资249.37万港元回购20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1191","01477","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2593486488","title":"每日卖空追踪 | 歌礼制药-B 12月22日卖空量成交34.1万股，卖空比例为11.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593486488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593486488?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392224,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月22日，跌3.77%，卖空量成交34.1万股，较上一交易日减少45.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163432a6c09b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163432a6c09b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01672","BK1515","BK1191","01477"],"gpt_icon":0},{"id":"2593486437","title":"歌礼制药-B盘中异动 早盘股价大跌5.38%报12.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593486437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593486437?lang=zh_cn&edition=full","pubTime":"2025-12-22 09:31","pubTimestamp":1766367085,"startTime":"0","endTime":"0","summary":"2025年12月22日早盘09时31分，歌礼制药-B股票出现异动，股价急速下跌5.38%。截至发稿，该股报12.300港元/股，成交量14.2万股，换手率0.01%，振幅2.69%。资金方面，该股资金流入45.036万港元，流出73.42万港元。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222093125a4681122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222093125a4681122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","BK1191","BK1574","01477","BK1515"],"gpt_icon":0},{"id":"2592276145","title":"突然，集体跳水！特朗普，最新宣布！","url":"https://stock-news.laohu8.com/highlight/detail?id=2592276145","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592276145?lang=zh_cn&edition=full","pubTime":"2025-12-20 18:59","pubTimestamp":1766228345,"startTime":"0","endTime":"0","summary":"美国总统特朗普的最新言论，对保险公司构成“利空”。特朗普周五表示，他将在未来几周内召集保险公司开会，以讨论降价问题。特朗普表示，保险公司赚了这么多钱，必须少赚一点。受此影响，联合健康集团、信诺保险、哈门那等医疗保险公司的股价突然大幅跳水，并全部翻绿。特朗普的上述言论，是在一场宣布与九家制药公司达成定价协议的新闻活动结束时作出的。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512203597491391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2592813296","title":"港股异动 | 森松国际(02155)现涨超8% 制药装备周期修复 公司为全球高端压力设备龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2592813296","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592813296?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:46","pubTimestamp":1766115972,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，森松国际现涨超8%，截至发稿，涨7.97%，报9.08港元，成交额2242.05万港元。开源证券发布研报称，森松国际作为全球高端压力设备龙头，受益制药行业CAPEX复苏及海外MNC扩产需求，新签订单快速增长，马来西亚二期产能释放缩短工程周期，叠加收购法玛度、比欧强化生物制药能力，“MVP”数智化解决方案驱动业绩高速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1183","01477","BK1191","BK1548","02155","BK1574","LU1171460220.USD"],"gpt_icon":0},{"id":"2592711132","title":"商务部发布2026年甘草及甘草制品出口配额公开招标投标企业名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2592711132","media":"北京日报客户端","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592711132?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:45","pubTimestamp":1766115900,"startTime":"0","endTime":"0","summary":"转自：北京日报客户端根据商务部2025年第78号公告，经审核，现将2026年甘草及甘草制品出口配额公开招标投标企业名单发布如下：一、符合鲜或干的甘草投标资格的企业（76家）1.亳州市中药饮片厂2.安徽贺林中药饮片科技有限公司3.安徽和济堂中药饮片有限公司4.安徽谓博中药股份有限公司5.安徽省本草国药饮片有限公司6.安徽盛林国药饮片有限公司7.亳州市盛林中药饮片有限公司8.安徽省天和中药材开发有限公","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-19/doc-inhcicep7777788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","BK1515","09939","BK1191","01477"],"gpt_icon":0},{"id":"2592903469","title":"歌礼制药-B(01672)12月18日斥资253.86万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592903469","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592903469?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:17","pubTimestamp":1766060221,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月18日斥资253.86万港元回购20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251218/31875436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01477","BK1515","01672","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2592970254","title":"今年港股最大Biotech IPO！英硅智能拟募资23亿港元冲刺AI制药第一股，AI制药能否完成全新药物研发再受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2592970254","media":"蓝鲸财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592970254?lang=zh_cn&edition=full","pubTime":"2025-12-18 19:36","pubTimestamp":1766057772,"startTime":"0","endTime":"0","summary":"以每股24.05港元的发行价计算，英硅智能将通过本次IPO募集至多约23亿港元，IPO市值则将达134.06亿港元，英硅智能将成为今年港股市场最大Biotech IPO。AI+制药再次引发业内关注。据悉，英硅智能在上市前经历了多轮融资，累计融资逾5.30亿美元。截至2025年6月30日，英硅智能持有的现金及等价物由2024年末的约1.26亿美元增至约2.13亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1766053261341090403","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2592514974","title":"每日卖空追踪 | 歌礼制药-B 12月18日卖空量成交21.7万股，卖空比例为11.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592514974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592514974?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046622,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月18日，跌3.81%，卖空量成交21.7万股，较上一交易日减少6.06%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163314a45aa164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163314a45aa164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1515","BK1191","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2592974571","title":"歌礼制药-B盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592974571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592974571?lang=zh_cn&edition=full","pubTime":"2025-12-18 09:33","pubTimestamp":1766021597,"startTime":"0","endTime":"0","summary":"2025年12月18日早盘09时33分，歌礼制药-B股票出现异动，股价大幅下挫5.33%。截至发稿，该股报12.430港元/股，成交量9.6万股，换手率0.01%，振幅5.86%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，科伦博泰生物-B、派格生物医药-B、基石药业-B涨幅较大，振幅较大的相关个股有歌礼制药-B、圣诺医药-B、拨康视云-B，振幅分别为5.26%、4.96%、4.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218093317953b66cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218093317953b66cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01672","BK1515","BK1161","01477","BK1191"],"gpt_icon":0},{"id":"2592910853","title":"欧康维视生物-B12月17日获主力加仓94.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592910853?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959355,"startTime":"0","endTime":"0","summary":"12月17日, 欧康维视生物-B股价涨1.37%，报收8.14元，成交金额340.9万元，换手率0.05%，振幅2.74%，量比0.54。欧康维视生物-B今日主力资金净流入94.5万元，上一交易日主力净流入25.8万元。该股近5个交易日下跌1.21%，主力资金累计净流入141.9万元；近20日主力资金累计净流出142.0万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162149a45603b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162149a45603b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2591989723","title":"歌礼制药-B(01672)12月16日斥资260.99万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591989723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591989723?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:03","pubTimestamp":1765886631,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月16日斥资260.99万港元回购20万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1191","BK1515","BK1574","01477","BK1161"],"gpt_icon":0},{"id":"2592361931","title":"每日卖空追踪 | 歌礼制药-B 12月16日卖空量成交12.5万股，卖空比例为1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592361931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592361931?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873821,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月16日，涨0.08%，卖空量成交12.5万股，较上一交易日减少37.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163323a4519de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163323a4519de5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1574","01672","BK1191","01477"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocumension.com","stockEarnings":[{"period":"1week","weight":-0.0369},{"period":"1month","weight":-0.0126},{"period":"3month","weight":-0.0554},{"period":"6month","weight":-0.249},{"period":"1year","weight":0.7778},{"period":"ytd","weight":0.7422}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"欧康维视生物是一家控股公司，主要从事眼科治疗药物的研发和商业化。该公司主要产品包括OT-401 (YUTIQ)、OT-1001 (ZERVIATE)、OT-502 (DEXYCU)、OT-301 (NCX 470)、OT-101和OT-202等。该公司业务主要在国内市场开展。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.116968},{"month":2,"riseRate":0.4,"avgChangeRate":-0.049128},{"month":3,"riseRate":0.6,"avgChangeRate":0.058111},{"month":4,"riseRate":0.4,"avgChangeRate":0.017956},{"month":5,"riseRate":0.6,"avgChangeRate":0.137077},{"month":6,"riseRate":0.8,"avgChangeRate":0.129408},{"month":7,"riseRate":0.4,"avgChangeRate":-0.027707},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.064893},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.082685},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.121217},{"month":11,"riseRate":0.333333,"avgChangeRate":0.004503},{"month":12,"riseRate":0.5,"avgChangeRate":0.067031}],"exchange":"SEHK","name":"欧康维视生物-B","nameEN":"OCUMENSION-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧康维视生物-B,01477,欧康维视生物-B股票,欧康维视生物-B股票老虎,欧康维视生物-B股票老虎国际,欧康维视生物-B行情,欧康维视生物-B股票行情,欧康维视生物-B股价,欧康维视生物-B股市,欧康维视生物-B股票价格,欧康维视生物-B股票交易,欧康维视生物-B股票购买,欧康维视生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}